Sutureless aortic bioprosthesis implantation is an alternative technique in high-risk patients undergoing aortic valve replacement with a possible reduction in the extracorporeal circuit time and reliable haemodynamic features. A 3F Enable (ATS Medical-Medtronic, Inc., Minneapolis, MN, USA) has shown very good results. We report the first upward displacement of 3F Enable three months post implantation.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3352697 | PMC |
| http://dx.doi.org/10.1093/icvts/ivr015 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Implantation of a sutureless aortic valve into the ring of a mechanical valve: an extreme solution for extreme cases.
Interdiscip Cardiovasc Thorac Surg
December 2024
Clinical Department for Cardiac Surgery, University Medical Centre Maribor, Maribor, Slovenia.
Reoperations due to dysfunction of artificial mechanical aortic valves represent a complex and high-risk surgical procedure, particularly for elderly patients. In this report, we present a case of an 81-year-old female patient where, due to structural degeneration of the mechanical valve, an emergency surgical procedure was indicated. After the removal of the valve leaflets, a sutureless aortic valve was implanted within the mechanical ring.
View Article and Find Full Text PDFComparison of Sutureless Aortic Valve Replacement and Transcatheter Aortic Valve Implantation: A Systematic Review and Meta-Analysis of Propensity Score Matching.
Rev Cardiovasc Med
November 2024
The First Clinical Medical College of Lanzhou University, 730000 Lanzhou, Gansu, China.
Background: To evaluate the clinical outcomes of sutureless aortic valve replacement (SUAVR) and transcatheter aortic valve implantation (TAVI).
Methods: We systematically searched the electronic database and the Clinical Trials Registry up to 31 February 2023. Random effects model risk ratio () and mean differences (MD) with corresponding 95% confidence intervals (CIs) were pooled for the clinical outcomes.
Sutureless Bioprostheses for Aortic Valve Replacement: An Updated Systematic Review with Long-Term Results.
J Clin Med
November 2024
Cardiovascular Research Institute, CARIM, 6629 ER Maastricht, The Netherlands.
Article Synopsis
- Aortic valve replacement (AVR) has seen an increased use of the Perceval sutureless bioprosthesis, which shows promising safety and reliability in both short- and mid-term outcomes, with some long-term data emerging.
- An updated systematic review of studies from 2015 to 2024 analyzed long-term outcomes of 5,221 patients with Perceval implants, revealing a long-term survival rate between 64.8% to 87.9% and low rates of complications such as structural valve degeneration and significant leaks.
- Despite limited data on sutureless bioprostheses, the encouraging results from existing studies suggest that Perceval could provide
Right anterior thoracotomy vs. upper hemisternotomy for aortic valve replacement with Perceval S: is there a difference?
Front Cardiovasc Med
October 2024
Cardiac Surgeon, Clinic for Cardiac Surgery, Dedinje Cardiovascular Institute, Belgrade, Serbia.
Background: Our study aimed to evaluate the early outcomes of aortic valve replacement with Perceval S sutureless valve through the right anterior thoracotomy and upper hemisternotomy approaches, and to determine if there are any differences between these two approaches.
Methods: We carried out a study using data from 174 patients who underwent minimally invasive Perceval S valve implantation for aortic valve stenosis between January 2018 and August 2023. This was a retrospective, single-center observational study.
Perceval sutureless bioprosthesis versus Trifecta sutured bioprosthesis for aortic valve replacement: immediate results of the study.
Kardiochir Torakochirurgia Pol
September 2024
Division of Cardiac Surgery, Department of Surgical Sciences, Tor Vergata University of Rome, Rome, Italy.
Introduction: The Perceval sutureless biological prosthesis for aortic valve replacement has been introduced with the rationale for shortening surgical, extracorporeal circulation and aortic cross-clamping times, in order to reduce postoperative complications.
Aim: To evaluate early hemodynamic performance and immediate outcomes of implantation of the Perceval sutureless bioprosthesis in comparison with the St. Jude Trifecta sutured bioprosthesis for aortic valve replacement (Perfecta study).
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!